The California Collaborative for Public Health Research (CPR3) unites community members, researchers and policymakers to improve the health and lives of all Californians. Using an equity-centered approach, CPR3 strengthens public health research collaboration across California through three pillars:
- Building partnerships across University of California (UC) campuses, community-based organizations and policy-making institutions
- Prioritizing and advancing policy-relevant public health research, including disease modeling and advanced analytics
- Promoting access to state public health data and data sharing across California research institutions
Priority Research Areas
More than 35 equity-focused research projects led by interdisciplinary teams representing all 10 UC campuses have been awarded through the CPR3 program. Totaling over $6M, funded projects are a foundational element of the initiative.
Featured Project
![](https://cpr3.ucsf.edu/sites/g/files/tkssra8501/f/styles/480x480/public/wysiwyg/morey_headshot.jpeg?itok=HImYaPO_)
California Pacific Islander Well-being And COVID-19 Economic Survey (CAPIWAVES)
Brittany Morey
UC Irvine, Department of Health, Society, & Behavior
Priority Research Areas
![](https://cpr3.ucsf.edu/sites/g/files/tkssra8501/f/styles/480x480/public/components/children-card.png?itok=cUnEsLrk)
![](https://cpr3.ucsf.edu/sites/g/files/tkssra8501/f/styles/480x480/public/components/hug-card.png?itok=kau1n7Yn)
![](https://cpr3.ucsf.edu/sites/g/files/tkssra8501/f/styles/480x480/public/components/social-card.png?itok=8wsEHzde)
![](https://cpr3.ucsf.edu/sites/g/files/tkssra8501/f/styles/480x480/public/components/communication-card.png?itok=ygRDvfob)
Visit our Partner
The UC Health & CDPH COVID Modeling Consortium unites UC investigators and California public health leaders in a forum to help guide policy decision-making during the COVID-19 pandemic.
UC Health & CDPH
COVID Modeling
Consortium
Latest News
Subscribe to Updates
Get CPR3 program updates by signing up through the link below! You can unsubscribe at any time.